Beranda › Migrain › Virginia › Charlottesville
Uji klinis Migrain di Charlottesville, VA
3 studi untuk Migrain mencari peserta di lokasi sekitar Charlottesville (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Menerima pesertaFase 3
- Pediatric Associates of Charlottesville, PLC (Private Pediatric Practice), Charlottesville
- Pediatric Research of Charlottesville, LLC (Regulatory Only), Charlottesville
- Pediatric Research of Charlottesville, LLC, Charlottesville
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Menerima pesertaFase 3
- Pediatric Associates of Charlottesville, PLC (Private Pediatric Practice), Charlottesville
- Pediatric Research of Charlottesville, LLC (Regulatory Only), Charlottesville
- Pediatric Research of Charlottesville, LLC, Charlottesville
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Menerima pesertaFase 3
- Pediatric Associates of Charlottesville, PLC /ID# 230628, Charlottesville
Uji klinis Migrain di kota lain
- Cincinnati, OH11 studi
- Austin, TX8 studi
- Miami, FL8 studi
- Philadelphia, PA8 studi
- Concord, CA8 studi
- Amherst, NY7 studi
- Omaha, NE7 studi
- Houston, TX7 studi
- Washington, DC7 studi
- Aurora, CO6 studi
- Stamford, CT6 studi
- San Diego, CA6 studi
Studi lain di Charlottesville
- Kanker Paru Non-Sel Kecil21 studi
- Leukemia Mieloid Akut16 studi
- Kanker Prostat15 studi
- Kanker Metastatik13 studi
- Kanker Endometrium13 studi
- Kanker (semua jenis)13 studi
- Kanker Paru13 studi
- Gagal Jantung11 studi
- Kanker Ovarium10 studi
- Kanker Kolorektal10 studi
- Diabetes Tipe 19 studi
- Kanker Payudara9 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.